A SPAC III Acquisition Corp.
Status: Live Deal
U=S+R R=S/10
IPO Proceeds, $M $60.00M
IPO Date Nov 8, 2024
CEO Mr. Claudius Tsang
Left Lead Maxim
IPO Cash in Trust 100.0%
SPAC Tenor 12+(2*3)
IPO Sector Technology
IPO Geography Global
Target Company Bioserica
Deal Announced Jan 27, 2025
Deal Size, $M TBD
Deal Sector Healthcare
Deal Geography Asia
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote TBD
ASPC ASPCU ASPCR

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.